Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-06-11 20:34:11 ET · period of report 2026-06-10 · accession 0001193125-26-268202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-11 20:34 | 2026-06-10+ | AXSM | JEFFS ROGER | Dir | S - Sale | $247.65 | -572 | 58.4K | -1.0% | -$141.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-10 | S | D | 286 | $246.18 | 58,653 | D | — | — | (F1) Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. (F2) These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025. |
| 2 | Common | Common Stock | 2026-06-11 | S | D | 286 | $249.12 | 58,367 | D | — | — | (F1) Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. (F2) These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025. |